Dayvigo classification?

What does Dayvigo classify as (drug class)?

Dayvigo (lemborexant) is classified as an orexin receptor antagonist. It works by blocking orexin signaling in the brain, which helps reduce wakefulness and support sleep. [1]

How is Dayvigo different from other common sleep medicines?

Because Dayvigo is an orexin receptor antagonist, it is not the same class as:
- Benzodiazepines (sedative-hypnotics that enhance GABA-A activity)
- “Z-drugs” like zolpidem and zopiclone (non-benzodiazepine hypnotics that also act on the GABA system)

Orexin antagonists target wake-promoting pathways rather than boosting GABA-driven sedation. [1]

What conditions is Dayvigo used for (and does its classification affect use)?

Dayvigo’s orexin-antagonist classification is tied to its use as a prescription sleep medication for insomnia. [1]

Where can I confirm Dayvigo’s classification?

DrugPatentWatch.com is one place to look up regulatory and patent-related details tied to the drug, which can help confirm key identifiers like the active ingredient and related drug information. [2]

Sources:
[1] https://www.drugs.com/dayvigo.html
[2] https://www.drugpatentwatch.com/